Clinical Trials in Dallas

Showing 4121-4140 of 17,468 trials

Lupus Landmark Study: A Prospective Registry and Biorepository

NCT05934149

The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).

Systemic Lupus Erythematosus (SLE)Lupus NephritisNeuropsychiatric Systemic Lupus Erythematosus

Lupus Research Alliance3,500 participantsStarted Jun 2023

Birmingham, Alabama, United States • Tucson, Arizona, United States • Beverly Hills, California, United States +18 more locations

TERMINATEDPhase 2< 1 mile

Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)

NCT05516498

This is a two part Phase IIa/b multicentre, randomised, double-blind, placebo-controlled, parallel group dose-ranging study to assess the efficacy, safety, and tolerability of the combination of zibotentan and dapagliflozin, and dapagliflozin monotherapy versus placebo in participants with cirrhosis with features of portal hypertension.

Liver Cirrhosis

AstraZeneca205 participantsStarted Oct 2022

Birmingham, Alabama, United States • Pasadena, California, United States • San Francisco, California, United States +47 more locations

Lupus Landmark Study: A Prospective Registry and Biorepository

Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)

Find Trials by Condition in Dallas

INSPIRE Trial for Abdominal Infections

Mepolizumab as Add-on Treatment IN Participants With COPD Characterized by Frequent Exacerbations and Eosinophil Level

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants With Chronic Rhinosinusitis With Nasal Polyps

A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

Cryoneurolysis of the Suprascapular Nerve for Perioperative Pain Control After Receiving a Reverse Total Shoulder Arthroplasty (RTSA)

A Real-World Evidence (RWE) Long-Term Follow-Up Study to Assess Outcomes of Alcon Monofocal Intraocular Lenses

Actis Total Hip System 2 Year Follow-up

Topical ENS-002 for Atopic Dermatitis in Adults

Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Observational Evaluation of Atopic Dermatitis in Pediatric Patients

Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Platinum Doublet Chemotherapy and Immunotherapy (MK-7902-008/E7080-G000-316/LEAP-008)

Study to Evaluate the Effect of GBT440 in Pediatrics With Sickle Cell Disease